IL ‐10 indirectly modulates functional activity of CD4 + CD28 null T‐lymphocytes through LFA ‐3 and HLA class II inhibition
Immunology · 2024
DOI: 10.1111/imm.13824 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunology, 2024. Verfasst von Alejandra García-Torre und 7 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, Hospital Universitario Central de Asturias, Oviedo, Spain. Hauptthemen laut MEDLINE: Interleukin-10, CD28 Antigens, CD4-Positive T-Lymphocytes, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Gobierno del Principado de Asturias, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Expansion of CD4 + CD28 null T‐lymphocytes is common in chronic heart failure (CHF) patients. Its ability to produce high levels of proinflammatory cytokines is probably the key role of these cells in CHF. IL‐10 is a candidate for limiting CD4 + CD28 null T‐lymphocyte responses, whereas tumour necrosis factor (TNF) is the cytokine most closely involved in the loss of CD28 expression. Serum levels of TNF and IL‐10 were measured in 65 CHF patients (mean age, 65.2 ± 13.84 years). Patients with an IL‐10/TNF ratio ≥1 had significantly lower levels of CD4 + CD28 null T‐lymphocytes than those with a ratio
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
- Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
- Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Oviedo, Spain.
- Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain.
- Section of Hemodynamics and Interventional Cardiology, Department of Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain.
ORCID-Profile: Alejandra García-Torre
Förderung
- Gobierno del Principado de Asturias
- Instituto de Salud Carlos III
Zitieren
APA
García-Torre, A., Bueno-García, E., Moro-García, M. A., López-Martínez, R., Rioseras, B., Díaz-Molina, B., Lambert, J. L., & Alonso-Arias, R. (2024). IL ‐10 indirectly modulates functional activity of CD4 + CD28 null T‐lymphocytes through LFA ‐3 and HLA class II inhibition. Immunology. https://doi.org/10.1111/imm.13824
Vancouver
García-Torre A, Bueno-García E, Moro-García MA, López-Martínez R, Rioseras B, Díaz-Molina B, et al. IL ‐10 indirectly modulates functional activity of CD4 + CD28 null T‐lymphocytes through LFA ‐3 and HLA class II inhibition. Immunology. 2024. doi:10.1111/imm.13824
BibTeX
@article{GarcaTorre2024,
author = {García-Torre, Alejandra and Bueno-García, Eva and Moro-García, Marco A and López-Martínez, Rocío and Rioseras, Beatriz and Díaz-Molina, Beatriz and Lambert, José Luis and Alonso-Arias, Rebeca},
title = {IL ‐10 indirectly modulates functional activity of CD4 + CD28 null T‐lymphocytes through LFA ‐3 and HLA class II inhibition},
journal = {Immunology},
year = {2024},
doi = {10.1111/imm.13824}
}
EUVIMED